Andere talen ZIVO Bioscience, Inc.

Aandelen

ZIVO

US98978N3098

Beurs gesloten - OTC Markets Andere beurzen 18:20:35 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
8,1 ^USD	+1,25%		+1,25%	+575,00%

15/03	ZIVO Bioscience, Inc. rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI
07/02	ZIVO Bioscience, Inc. Rapporteert aanvullende bevindingen van het positieve 42-daagse onderzoek naar coccidiose	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

ZIVO Bioscience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	15/03
ZIVO Bioscience Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study	07/02
ZIVO Bioscience, Inc. Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study	07/02
ZIVO Bioscience Announces Uplisting to OTCQB Market	29/01
Zivo Bioscience Reports Positive Efficacy Results from 42-Day Validation Study with Non-Antibiotic Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens	23/01
ZIVO Bioscience, Inc. announced that it has received $0.531142 million in funding	16/01
ZIVO Bioscience, Inc. announced that it expects to receive $0.531142 million in funding	04/01
ZIVO Bioscience, Inc. announced that it has received $0.308936 million in funding	27/12
ZIVO Bioscience, Inc. announced that it expects to receive $0.308936 million in funding	12/12
ZIVO Bioscience, Inc. announced that it has received $0.2 million in funding	05/12
ZIVO Bioscience, Inc.(NasdaqCM:ZIVO) dropped from S&P TMI Index	29/11
ZIVO Bioscience, Inc.(OTCPK:ZIVO) dropped from NASDAQ Composite Index	24/11
ZIVO Bioscience, Inc. announced that it expects to receive $0.15 million in funding	16/11
ZIVO Bioscience, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
Zivo Bioscience Insider Bought Shares Worth $199,600, According to a Recent SEC Filing	30-10-23
ZIVO Bioscience Initiates 42-Day Validation Study with Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens	30-10-23
ZIVO Bioscience Announces Reverse Stock Split	26-10-23
ZIVO Bioscience : Dawon James Small Cap Growth Conference Presentation	12-10-23
ZIVO Bioscience to Present at the Dawson James Small Cap Growth Conference	03-10-23
Trial Results Confirm Efficacy of ZIVO Bioscience's Non-Antibiotic Product Candidate for the Prevention and Treatment of Coccidiosis in Broiler Chickens	20-09-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen ZIVO Bioscience, Inc.

Aandelen

ZIVO

US98978N3098

Andere talen

Filters